Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Physiological Model Solutions
Essential characterization techniques for organoid cell models.
April 4, 2025 -
2 min read
Cell and Gene Therapy, Biologics, Cancer
Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.
April 2, 2025 -
3 min read
Cancer
The mixed lymphocyte reaction (MLR): a classic assay for modern drug immune assessment.
March 25, 2025 -
3 min read
Biologics
The economic factors shaping expression system decisions and manufacturing strategies.
March 24, 2025 -
3 min read
Infectious Diseases
World tuberculosis day 2025: Raising awareness to support global TB control efforts.
March 12, 2025 -
6 min read
Reproductive Health
Revolutionizing newborn screening: next-generation sequencing in genetic disease research.
March 7, 2025 -
3 min read
Cancer
Utilizing AlphaLISA technology to elucidate CDK2 signaling pathways in CCNE-1 amplified ovarian cancer.
March 5, 2025 -
8 min read
Cancer
How Mimix™ Reference Standards are generated, and how they can support your oncology research.
February 28, 2025 -
7 min read
Functional Genomic Screening
Unlocking biological questions with functional genomics.
February 27, 2025 -
6 min read
